Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction
- 1 February 2002
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 17 (2) , 95-102
- https://doi.org/10.1046/j.1525-1497.2002.10438.x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Effects of Socioeconomic Status on Access to Invasive Cardiac Procedures and on Mortality after Acute Myocardial InfarctionNew England Journal of Medicine, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Cost Effectiveness of Simvastatin Treatment to Lower Cholesterol Levels in Patients with Coronary Heart DiseaseNew England Journal of Medicine, 1997
- Management of Primary HyperlipidemiaNew England Journal of Medicine, 1995
- Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible MechanismsNew England Journal of Medicine, 1995
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994
- Trends in the use of drag therapies in patients with acute myocardial infarction: 1988 to 1992Journal of the American College of Cardiology, 1994
- Is knowing your cholesterol number harmful?Journal of Clinical Epidemiology, 1994
- Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment PanelPublished by American Medical Association (AMA) ,1993